The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2019

Filed:

Nov. 15, 2016
Applicant:

Obi Pharma, Inc., Taipei, TW;

Inventors:

Jian-Xin Duan, South San Francisco, CA (US);

Yeyu Cao, South San Francisco, CA (US);

Xiaohong Cai, South San Francisco, CA (US);

Hailong Jiao, South San Francisco, CA (US);

Jing Yuan Ma, South San Francisco, CA (US);

Mark Matteucci, South San Francisco, CA (US);

Assignee:

OBI PHARMA, INC., Taipei, TW;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 203/22 (2006.01); A61K 31/396 (2006.01); G06F 16/951 (2019.01); G06F 16/954 (2019.01); G01N 29/02 (2006.01); G01N 29/22 (2006.01); G06F 3/0484 (2013.01); G06F 17/22 (2006.01); H03H 9/02 (2006.01); H03H 9/10 (2006.01); H03H 9/25 (2006.01); A61P 35/00 (2006.01); C07F 9/564 (2006.01);
U.S. Cl.
CPC ...
G06F 16/951 (2019.01); A61P 35/00 (2018.01); C07F 9/564 (2013.01); G01N 29/022 (2013.01); G01N 29/222 (2013.01); G06F 3/04842 (2013.01); G06F 16/954 (2019.01); G06F 17/2235 (2013.01); H03H 9/02622 (2013.01); H03H 9/1092 (2013.01); H03H 9/25 (2013.01); C07B 2200/07 (2013.01); G01N 2291/0255 (2013.01); G01N 2291/0256 (2013.01); G01N 2291/0423 (2013.01);
Abstract

Provided herein are optically active compounds of the formulae (ii); and (III) and pharmaceutical compositions thereof. Also provided herein are processes of making these compounds and resolving the racemic mixture or the enrichment of same with in one of its enantiomers to provide (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis(ethylene)phosphoramidate, and methods of treating cancer comprising administering such compounds.


Find Patent Forward Citations

Loading…